Pedro Fonte

4.3k citations
67 papers · 3.2k indexed · 1 hit paper · h-index 34

Pedro Fonte

64 papers receiving 3.1k citations

Hit Papers

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carrie...231202320262024202550100150200

Peers

Pedro Fonte
Comparison fields: 5 of 142
  • Pharmaceutical Science 1.3k
  • Biomaterials 813
  • Molecular Medicine 169
  • Food Science 428
  • Biochemistry 115
Replace Ana Cristina Calpena with:
Ana Cristina Calpena Spain
Amit Jain India
Usha Y. Nayak India
Stefano Giovagnoli Italy
Luca Casettari Italy
Sofia A. Costa Lima Portugal
Ranjita Shegokar Germany
Paolo Blasi Italy
Quangang Zhu China
Young Wook Choi South Korea
Pedro Fonte relative to Ana Cristina Calpena Spain Ana Cristina Calpena's profile →
Citations per field
00.5×1.5×2.3×
Ana Cristina Calpena · 1×
Citations per year

Countries citing papers authored by Pedro Fonte

Since Specialization
Citations

This map shows the geographic impact of Pedro Fonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Fonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Fonte more than expected).

Fields of papers citing papers by Pedro Fonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Fonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Fonte. The network helps show where Pedro Fonte may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pedro Fonte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pedro Fonte Line = papers co-authored together Pedro Fonte links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20250
4 202426
5 20241
6 202411
7 202327
8 202317
9 202214
10 202265
11 20218
12 202168
13 202112
14 202014
15 201922
16 2017110
17 201636
18 201545
19 201352
20 2011146

About Pedro Fonte

Pedro Fonte is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 67 papers that have together received 3.2k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (25 papers), Nanoparticle-Based Drug Delivery (12 papers), Advancements in Transdermal Drug Delivery (12 papers), RNA Interference and Gene Delivery (10 papers), Protein purification and stability (10 papers), Drug Solubulity and Delivery Systems (8 papers), Lipid Membrane Structure and Behavior (7 papers) and Proteins in Food Systems (6 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Biomaterials (813 citations) and Molecular Medicine (169 citations). Pedro Fonte has collaborated with scholars based in Portugal, Brazil and Spain. Frequent co-authors include Bruno Sarmento, Salette Reis, Francisca Araújo, Cláudia Viegas, Flávia Sousa, Vítor Seabra, Domingos Ferreira, Manuela Pintado, Ana S. Macedo and Hélder A. Santos. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026